SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,940,936 | -51.1% | 6,474,348 | 0.0% | 0.03% | -62.8% |
| Q2 2023 | $8,060,563 | -29.3% | 6,474,348 | 0.0% | 0.08% | -90.7% |
| Q1 2023 | $11,394,852 | +24.5% | 6,474,348 | +113.9% | 0.84% | +110.2% |
| Q4 2022 | $9,154,285 | -40.6% | 3,026,210 | 0.0% | 0.40% | -12.6% |
| Q3 2022 | $15,403,000 | +23.5% | 3,026,210 | 0.0% | 0.46% | +25.8% |
| Q2 2022 | $12,468,000 | +112.7% | 3,026,210 | +209.5% | 0.36% | +33.2% |
| Q1 2022 | $5,861,000 | +42.7% | 977,663 | +81.1% | 0.27% | +10.9% |
| Q4 2021 | $4,108,000 | -16.9% | 539,860 | 0.0% | 0.25% | +133.0% |
| Q3 2021 | $4,945,000 | – | 539,860 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |